Creative Planning
TENX icon

Creative Planning’s Tenax Therapeutics TENX Stock Holding History

Creative Planning’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Hold
0
– -$1K – 3531
2017
Q2 		– Hold
0
– – – 4498
2017
Q1 		– Sell
-1
Closed -$36.3K – 4499
2016
Q4 		$60K Hold
1
– – ﹤0.01% 2247
2016
Q3 		$60K Buy
+1
New +$78.9K ﹤0.01% 2219
2015
Q3 		– Sell
-1
Closed -$162K – 4356
2015
Q2 		$162K Buy
+1
New +$114K ﹤0.01% 913

Other funds holding TENX

FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Creative Planning's TENX Position: Q3 2017 in Review

Creative Planning held its Tenax Therapeutics (TENX) position steady in Q3 2017 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3531.

Creative Planning first reported a position in TENX in Q2 2015 and has held it in 3 quarters since. The position peaked at $162K in Q2 2015. 11 funds tracked by Wall St. Rank hold TENX as of Q3 2017.

  • Creative Planning held 0 shares of Tenax Therapeutics worth $0 as of Q3 2017.
  • Creative Planning left its Tenax Therapeutics share count unchanged in Q3 2017.
  • Tenax Therapeutics made up ﹤0.01% of Creative Planning's portfolio in Q3 2017, its #3531 holding.
  • Creative Planning first reported a position in Tenax Therapeutics in Q2 2015 and has held it in 3 quarters since.
  • Creative Planning's Tenax Therapeutics position peaked at $162K in Q2 2015.
  • 11 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.